Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
Mueller RB, Reshiti N, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, Schiff M, Spaeth M, von Kempis J; SCQM physicians. Mueller RB, et al. Among authors: von kempis j. Clin Rheumatol. 2017 Jan;36(1):59-66. doi: 10.1007/s10067-016-3468-6. Epub 2016 Nov 12. Clin Rheumatol. 2017. PMID: 27838788 Free article.
Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes.
Thalmann R, von Kempis J, Zgraggen A, Graf N, Schiff M, Sokka T, Dietrich T, Schulze-Koops H, Mueller RB. Thalmann R, et al. Among authors: von kempis j. Clin Exp Rheumatol. 2022 Mar;40(3):589-595. doi: 10.55563/clinexprheumatol/jpysud. Epub 2021 May 5. Clin Exp Rheumatol. 2022. PMID: 34001300
Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort.
Mueller RB, Kaegi T, Haile SR, Schulze-Koops H, Schiff M, von Kempis J. Mueller RB, et al. Among authors: von kempis j. RMD Open. 2018 Jun 6;4(1):e000673. doi: 10.1136/rmdopen-2018-000673. eCollection 2018. RMD Open. 2018. PMID: 29955385 Free PMC article.
Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol.
Mueller RB, Spaeth M, von Restorff C, Ackermann C, Schulze-Koops H, von Kempis J. Mueller RB, et al. Among authors: von restorff c, von kempis j. J Clin Med. 2019 Mar 3;8(3):302. doi: 10.3390/jcm8030302. J Clin Med. 2019. PMID: 30832414 Free PMC article.
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Mueller RB, Schulze-Koops H, Furst DE, Cohen SB, Kwok K, Wang L, Killeen T, von Kempis J. Mueller RB, et al. Among authors: von kempis j. Clin Rheumatol. 2022 Apr;41(4):1045-1055. doi: 10.1007/s10067-021-05908-z. Epub 2022 Jan 1. Clin Rheumatol. 2022. PMID: 34973077 Free PMC article.
72 results